Getinge AB Share Price

Equities

GETI B

SE0000202624

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 16:29:46 17/05/2024 BST 5-day change 1st Jan Change
185.5 SEK -2.42% Intraday chart for Getinge AB -12.46% -17.30%

Financials

Sales 2024 * 34.12B 3.19B 251B Sales 2025 * 35.71B 3.33B 262B Capitalization 50.52B 4.72B 371B
Net income 2024 * 2.79B 261M 20.51B Net income 2025 * 3.25B 303M 23.88B EV / Sales 2024 * 1.67 x
Net Debt 2024 * 6.4B 598M 47.05B Net Debt 2025 * 4.38B 409M 32.19B EV / Sales 2025 * 1.54 x
P/E ratio 2024 *
18.5 x
P/E ratio 2025 *
15.7 x
Employees 11,862
Yield 2024 *
2.56%
Yield 2025 *
2.86%
Free-Float 79.06%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.42%
1 week-12.46%
Current month-21.06%
1 month-11.62%
3 months-9.64%
6 months-15.37%
Current year-17.30%
More quotes
1 week
183.80
Extreme 183.8
217.80
1 month
183.80
Extreme 183.8
240.20
Current year
183.80
Extreme 183.8
240.20
1 year
174.20
Extreme 174.2
268.80
3 years
174.20
Extreme 174.2
431.60
5 years
126.70
Extreme 126.7
431.60
10 years
74.74
Extreme 74.74
431.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 30/04/17
Director of Finance/CFO - 14/09/22
Chairman 63 31/12/96
Members of the board TitleAgeSince
Director/Board Member 68 31/12/06
Director/Board Member 73 31/12/88
Chairman 63 31/12/96
More insiders
Date Price Change Volume
17/05/24 185.5 -2.42% 1,887,277
16/05/24 190.1 -0.65% 2,023,731
15/05/24 191.4 -11.86% 6,669,554
14/05/24 217.1 +1.83% 678,657
13/05/24 213.2 +0.61% 1,227,549

Delayed Quote Nasdaq Stockholm, May 17, 2024 at 04:29 pm

More quotes
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.; - hospital sterilization equipment (29.4%); - contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications. Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%). At the end of 2021, the group had 20 production sites worldwide. Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
185.5 SEK
Average target price
229.2 SEK
Spread / Average Target
+23.57%
Consensus
  1. Stock Market
  2. Equities
  3. GETI B Stock